TET2 and head and neck squamous cell carcinoma: In another study, the expression of Tet methylcytosine dioxygenase 2 (TET2) was reduced in HNSCC patients, and the level of 5-hydroxymethylcytosine (5 hmC) was associated with decreased overall survival [18].